SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 16072.
  • 2
    Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 1928.
  • 3
    Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006; 67: 121925.
  • 4
    Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, et al. Psychiatric disorders in patients with fibromyalgia: a multicenter investigation. Psychosomatics 1999; 40: 5763.
  • 5
    Hassett AL, Cone JD, Patella SJ, Sigal LH. The role of catastrophizing in the pain and depression of women with fibromyalgia syndrome. Arthritis Rheum 2000; 43: 2493500.
  • 6
    Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, et al. Family study of fibromyalgia. Arthritis Rheum 2004; 50: 94452.
  • 7
    Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, et al. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 1999; 6: 4339.
  • 8
    Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Kruger M, Schoeps P, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 1999; 42: 24828.
  • 9
    Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM. Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses. Pain 2004; 110: 44960.
  • 10
    Staud R, Price DD, Robinson ME, Vierck CJ Jr. Body pain area and pain-related negative affect predict clinical pain intensity in patients with fibromyalgia. J Pain 2004; 5: 33843.
  • 11
    Staud R, Vierck CJ, Robinson ME, Price DD. Overall fibromyalgia pain is predicted by ratings of local pain and pain-related negative affect: possible role of peripheral tissues. Rheumatology (Oxford) 2006; 45: 140915.
  • 12
    Finset A, Wigers SH, Gotestam KG. Depressed mood impedes pain treatment response in patients with fibromyalgia. J Rheumatol 2004; 31: 97680.
  • 13
    Zautra AJ, Johnson LM, Davis MC. Positive affect as a source of resilience for women in chronic pain. J Consult Clin Psychol 2005; 73: 21220.
  • 14
    Nicassio PM, Schuman C. The prediction of fatigue in fibromyalgia. J Musculoskelet Pain 2005; 13: 1525.
  • 15
    Zautra AJ, Fasman R, Parish BP, Davis MC. Daily fatigue in women with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Pain 2007; 128: 12835.
  • 16
    Kassam A, Patten SB. Major depression, fibromyalgia and labour force participation: a population-based cross-sectional study. BMC Musculoskelet Disord 2006; 7: 4.
  • 17
    Burckhardt CS, Clark SR, Bennett RM. Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 1993; 20: 4759.
  • 18
    Zautra A, Smith B, Affleck G, Tennen H. Examinations of chronic pain and affect relationships: applications of a dynamic model of affect. J Consult Clin Psychol 2001; 69: 78695.
  • 19
    Zautra AJ, Fasman R, Reich JW, Harakas P, Johnson LM, Olmsted ME, et al. Fibromyalgia: evidence for deficits in positive affect regulation. Psychosom Med 2005; 67: 14755.
  • 20
    Pressman SD, Cohen S. Does positive affect influence health? Psychol Bull 2005; 131: 92571.
  • 21
    Bradburn NM. The structure of psychological well-being. Chicago: Aldine; 1969.
  • 22
    Kim KA, Mueller DJ. To balance or not to balance: confirmatory factor analysis of the Affect-Balance Scale. J Happiness Stud 2001; 2: 289306.
  • 23
    Macintosh R. A confirmatory factor analysis of the Affect Balance Scale in 38 nations: a research note. Soc Psychol Q 1998; 61: 8395.
  • 24
    Schwartz RM, Garamoni GL. Cognitive balance and psychopathology: evaluation of an information processing model of positive and negative states of mind. Clin Psychol Rev 1989; 9: 27194.
  • 25
    Fredman L, Hawkes WG, Black S, Bertrand RM, Magaziner J. Elderly patients with hip fracture with positive affect have better functional recovery over 2 years. J Am Geriatr Soc 2006; 54: 107481.
  • 26
    Moskowitz JT. Positive affect predicts lower risk of AIDS mortality. Psychosom Med 2003; 65: 6206.
  • 27
    Strand EB, Zautra AJ, Thoresen M, Odegard S, Uhlig T, Finset A. Positive affect as a factor of resilience in the pain-negative affect relationship in patients with rheumatoid arthritis. J Psychosom Res 2006; 60: 47784.
  • 28
    Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988; 54: 106370.
  • 29
    Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991; 18: 72833.
  • 30
    Fallon J, Bujak DI, Guardino S, Weinstein A. The Fibromyalgia Impact Questionnaire: a useful tool in evaluating patients with post–Lyme disease syndrome. Arthritis Care Res 1999; 12: 427.
  • 31
    Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV 3rd, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA 1994; 272: 174956.
  • 32
    First MB, Gibbon M, Spitzer RL, Williams JB. User's guide for the structured clinical interview for DSM-IV axis I disorders: research version (SCID-I, version 2.0, February 1996 final version). Washington (DC): American Psychiatric Press; 1996.
  • 33
    Steiner JL, Tebes JK, Sledge WH, Walker ML. A comparison of the structured clinical interview for DSM-III-R and clinical diagnoses. J Nerv Ment Dis 1995; 18: 3659.
  • 34
    Zanarini MC, Frankenburg FR. Attainment and maintenance of reliability of axis I and II disorders over the course of a longitudinal study. Compr Psychiatry 2001; 42: 36974.
  • 35
    Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW. Case definitions for public health surveillance. MMWR Recomm Rep 1990; 39: 143.
  • 36
    SPSS for Windows, version 14.0.0. Chicago: SPSS; 2005.
  • 37
    R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2007.
  • 38
    Wright SP. Adjusted P-values for simultaneous inference. Biometrics 1992; 48: 100513.
  • 39
    Porter-Moffitt S, Gatchel RJ, Robinson RC, Deschner M, Posamentier M, Polatin P, et al. Biopsychosocial profiles of different pain diagnostic groups. J Pain 2006; 7: 30818.
  • 40
    Suhr JA. Neuropsychological impairment in fibromyalgia: relation to depression, fatigue, and pain. J Psychosom Res 2003; 55: 3219.
  • 41
    Palomino RA, Nicassio PM, Greenberg MA, Medina EP Jr. Helplessness and loss as mediators between pain and depressive symptoms in fibromyalgia. Pain 2007; 129: 18594.
  • 42
    Crawford JR, Henry JD. The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol 2004; 43: 24565.
  • 43
    McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav 2003; 43: 215.
  • 44
    Gillespie CF, Nemeroff CB. Hypercortisolemia and depression. Psychosom Med 2005; 67 Suppl 1: S268.
  • 45
    Agelink MW, Majewski T, Wurthmann C, Postert T, Linka T, Rotterdam S, et al. Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone. J Affect Disord 2001; 62: 18798.
  • 46
    Sarzi-Puttini P, Atzeni F, Diana A, Doria A, Furlan R. Increased neural sympathetic activation in fibromyalgia syndrome. Ann N Y Acad Sci 2006; 1069: 10917.
  • 47
    Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, et al. Fibromyalgia syndrome. J Rheumatol 2007; 34: 141525.
  • 48
    Dadabhoy D, Clauw DJ. Fibromyalgia: progress in diagnosis and treatment. Curr Pain Headache Rep 2005; 9: 399404.
  • 49
    Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997; 4: 13453.
  • 50
    Martinez-Lavin M. Fibromyalgia as a sympathetically maintained pain syndrome [review]. Curr Pain Headache Rep 2004; 8: 3859.
  • 51
    DeMaria S Jr, Hassett AL, Sigal LH. N-methyl-D-aspartate receptor-mediated chronic pain: new approaches to fibromyalgia syndrome etiology and therapy. J Musculoskelet Pain 2007; 15: 3344.
  • 52
    Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX, et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 2003; 48: 291622.
  • 53
    Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med 2004; 66: 83744.
  • 54
    Hassett AL, Maclean JR, Stuart MR, Peterson C, Buyske S, Park N, et al. Further validation for the observational evaluation of psychological well-being in rheumatoid arthritis: data from the ATTAIN study [abstract]. Ann Rheum Dis 2007; 66 Suppl 2: 121.
  • 55
    Hassett AL, Simonelli LE, Radvanski DC, Savage SV, Sigal LH. Affect balance and catastrophizing in patients with fibromyalgia (FM) [abstract]. Arthritis Rheum 2007; 56 Suppl 9: S531.